Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 7;22(4):1138-1147.
doi: 10.1021/acs.jproteome.2c00475. Epub 2023 Feb 10.

LC-MS/MS-PRM Quantification of IgG Glycoforms Using Stable Isotope Labeled IgG1 Fc Glycopeptide Standard

Affiliations

LC-MS/MS-PRM Quantification of IgG Glycoforms Using Stable Isotope Labeled IgG1 Fc Glycopeptide Standard

Miloslav Sanda et al. J Proteome Res. .

Abstract

Targeted quantification of proteins is a standard methodology with broad utility, but targeted quantification of glycoproteins has not reached its full potential. The lack of optimized workflows and isotopically labeled standards limits the acceptance of glycoproteomics quantification. In this work, we introduce an efficient and streamlined chemoenzymatic synthesis of a library of isotopically labeled glycopeptides of IgG1 which we use for quantification in an energy optimized LC-MS/MS-PRM workflow. Incorporation of the stable isotope labeled N-acetylglucosamine enables an efficient monitoring of all major fragment ions of the glycopeptides generated under the soft higher-energy C-trap dissociation (HCD) conditions, which reduces the coefficients of variability (CVs) of the quantification to 0.7-2.8%. Our results document, for the first time, that the workflow using a combination of stable isotope labeled standards with intrascan normalization enables quantification of the glycopeptides by an electron transfer dissociation (ETD) workflow, as well as the HCD workflow, with the highest sensitivity compared to traditional workflows. This was exemplified by a rapid quantification (13 min) of IgG1 Fc glycoforms from COVID-19 patients.

Keywords: Glycopeptide Synthesis; Glycoproteomics; Immunoglobulins; Mass Spectrometry; PRM Analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. Synthesis of the 13C-Labeled N-Acetylglucosamine (GlcNAc)–Peptide Precursors (A) and Different N-Glycan Oxazolines (B)
Scheme 2
Scheme 2. Chemoenzymatic Synthesis of Various Isotope Labeled IgG1 Fc Glycopeptides
Figure 1
Figure 1
Selectivity of glycopeptide fragments recorded under different CE conditions: Low CE condition (NCE 11), signal of antenna loss Y fragment ion (left); high collision energy (NCE 35), signal GlcNAc peptide Y fragment ion; high collision energy (NCE 35) signal of HexNAcHex oxonium ion.
Figure 2
Figure 2
Comparison of the intensities of the most intense soft fragment (low CE) and peptide-HexNAc fragment (high CE) obtained under the following conditions: (A) low NCE, 10 Da window with (C) zoom of qualification ions; (B) high NCE, 10 Da window with (D) zoom of quantification ions.
Figure 3
Figure 3
Comparison of the intensities and RSDs of the quantification of three IgG glycoforms (G0F, G1F, and G2F) in the samples of unfractionated human serum. We used HCD with low (11) and high (35) NCE as well as narrow (1.6 Da) and wide (10 Da) window as described in the legend.
Figure 4
Figure 4
Selectivity of the (A, C) intrascan (10 Da) and (B, D) interscan (1.6 Da) normalization methodology recorded under high and low CE HCD; (C, D) extracted ion chromatography (XIC) signal of peptide-HexNAc Y ion and (A,B) low CE signal of antenna loss Y ion.

Update of

Similar articles

Cited by

References

    1. Rudd P. M.; Dwek R. A. Glycosylation: heterogeneity and the 3D structure of proteins. Crit Rev. Biochem Mol. Biol. 1997, 32 (1), 1–100. 10.3109/10409239709085144. - DOI - PubMed
    1. Cummings R. D. The repertoire of glycan determinants in the human glycome. Mol. Biosyst 2009, 5 (10), 1087–104. 10.1039/b907931a. - DOI - PubMed
    1. Fan Y.; Hu Y.; Yan C.; Goldman R.; Pan Y.; Mazumder R.; Dingerdissen H. M. Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer. Sci. Rep 2018, 8 (1), 4322.10.1038/s41598-018-22345-2. - DOI - PMC - PubMed
    1. Dennis J. W.; Nabi I. R.; Demetriou M. Metabolism, cell surface organization, and disease. Cell 2009, 139 (7), 1229–41. 10.1016/j.cell.2009.12.008. - DOI - PMC - PubMed
    1. Ng B. G.; Freeze H. H. Perspectives on Glycosylation and Its Congenital Disorders. Trends Genet 2018, 34 (6), 466–476. 10.1016/j.tig.2018.03.002. - DOI - PMC - PubMed

Publication types